Gray W. Wood

Gründer bei TVAX BIOM

84 Jahre

Consumer Services

Health Technology

Commercial Services

Profil

Gray W.
Wood is the founder of TVAX Biomedical, Inc. (founded in 2011) and TVAX Biomedical I LLC (founded in 2004).
He holds the title of Chairman & Chief Scientific Officer at TVAX Biomedical, Inc. and Chairman, President & Chief Executive Officer at TVAX Biomedical I LLC.
Currently, Dr. Wood is the Director at ELIAS Animal Health LLC.
In the past, he worked as the Director-Cancer Immunotherapy Laboratory at Wayne State University (Michigan) and the University of Kansas.
Dr. Wood completed his undergraduate degree at Kalamazoo College and obtained a doctorate degree from the State University of New York at Buffalo.

Aktive Positionen von Gray W. Wood

Unternehmen	Position	Beginn
TVAX BIOM	Gründer	14.07.2011
TVAX Biomedical I LLC TVAX Biomedical I LLC Part of TVAX Biomedical, Inc., TVAX Biomedical I LLC is a clinical stage development company based in Lenexa, KS. TVAX Biomedical I LLC specializes in the development of a novel targeted cell-based immunotherapy for the treatment of cancer. The company's immunotherapeutic cancer treatment platform is based on over 50 years of scientific and medical research into the interactions between cancer and the immune system. TVAX Immunotherapy employs the natural ability of T cells to kill cancer cells and has demonstrated the ability to effectively treat numerous cancers without many of the undesirable side effects associated with radiation and chemotherapy. The key difference between TVAX Biomedical I LLC and other cancer immunotherapy companies is that it uses both cancer vaccine pretreatment to generate cancer-specific T cells and activated "killer" T cell treatment, which has demonstrated significant efficacy. The proprietary treatment has received orphan product designation from the FDA for the prevention and treatment of any primary central nervous system malignancy, providing the company with seven years of marketing exclusivity following FDA marketing approval. The company was founded by Catherine E. Lucasey, Frank P. Holladay, Gray W. Wood. Gray W. Wood has been the CEO of the company since 2004.	Vorstandsvorsitzender	-
ELIAS Animal Health LLC ELIAS Animal Health LLC Miscellaneous Commercial ServicesCommercial Services Operates as a medical biotechnology company that develops treatments for cancer in companion animals	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Gray W. Wood

Ehemalige bekannte Positionen von Gray W. Wood

Unternehmen	Position	Ende
Wayne State University (Michigan) Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Gray W. Wood im Detail an

Ausbildung von Gray W. Wood

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Gray W. Wood im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
TVAX Biomedical, Inc. TVAX Biomedical, Inc. BiotechnologyHealth Technology Manufactures and sells healthcare products	Health Technology
ELIAS Animal Health LLC ELIAS Animal Health LLC Miscellaneous Commercial ServicesCommercial Services Operates as a medical biotechnology company that develops treatments for cancer in companion animals	Commercial Services
Wayne State University (Michigan) Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kalamazoo College Kalamazoo College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
State University of New York at Buffalo State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
TVAX Biomedical I LLC TVAX Biomedical I LLC Part of TVAX Biomedical, Inc., TVAX Biomedical I LLC is a clinical stage development company based in Lenexa, KS. TVAX Biomedical I LLC specializes in the development of a novel targeted cell-based immunotherapy for the treatment of cancer. The company's immunotherapeutic cancer treatment platform is based on over 50 years of scientific and medical research into the interactions between cancer and the immune system. TVAX Immunotherapy employs the natural ability of T cells to kill cancer cells and has demonstrated the ability to effectively treat numerous cancers without many of the undesirable side effects associated with radiation and chemotherapy. The key difference between TVAX Biomedical I LLC and other cancer immunotherapy companies is that it uses both cancer vaccine pretreatment to generate cancer-specific T cells and activated "killer" T cell treatment, which has demonstrated significant efficacy. The proprietary treatment has received orphan product designation from the FDA for the prevention and treatment of any primary central nervous system malignancy, providing the company with seven years of marketing exclusivity following FDA marketing approval. The company was founded by Catherine E. Lucasey, Frank P. Holladay, Gray W. Wood. Gray W. Wood has been the CEO of the company since 2004.